The 2026 expansion of the Joint Clinical Assessment (JCA) mandate is the most significant regulatory shift in a decade. For the individual Market Access or HEOR professional, success now depends on mastering the PICO Framework and navigating the complexities of Darwin EU 2.0.
The Single Delegate Entry for the European RWE & Market Access Summit is your opportunity to gain a competitive edge. This is not a theoretical conference, it is a high-intensity, two-day strategic forum designed to equip you with non-academic, actionable toolkits for evidence implementation and payer negotiation.
JCA & PICO Strategy: Learn to manage PICO multiplicity and define comparator rationales that meet 27 Member State requirements simultaneously.
Advanced RWE Operations: Reduce timelines from data collection to submission using AI-driven quality improvements and automated evidence generation.
Pricing & Value Communication: Navigate outcomes-based agreements and predictive pricing analytics to align with G-BA, NICE, HAS, and AIFA expectations.
Evidence Implementation: Gain first-hand insights from the 2025-2026 JCA pilots and learn to mitigate bias in decision-grade evidence frameworks.
This pass is specifically curated for senior individual contributors and department heads who need to anchor their company’s strategy:
Directors & Leads: RWE, HEOR, and Evidence Strategy.
Senior Managers: Market Access, Pricing, and Reimbursement.
Specialists: Regulatory Strategy and Medical Affairs teams.
Experts: Health Economists and AI in Healthcare innovators.
| Feature | Professional Benefit |
| Pass Type | Single Entry / Individual Delegate |
| Faculty Access | Direct interaction with 30+ expert speakers from Pharma & HTA bodies |
| Networking | 1:1 engagement with a curated assembly of 200+ senior leaders |
| Location | Amsterdam – The heart of European regulatory science |
| Dates | October 21-22, 2026 |
€ 1499 Original price was: € 1499.€ 999Current price is: € 999.